Encompass Health Corporation $EHC Stock Holdings Boosted by Tectonic Advisors LLC

Tectonic Advisors LLC raised its stake in shares of Encompass Health Corporation (NYSE:EHC) by 153.3% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 19,675 shares of the company’s stock after purchasing an additional 11,907 shares during the quarter. Tectonic Advisors LLC’s holdings in Encompass Health were worth $2,390,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Fifth Third Wealth Advisors LLC boosted its stake in Encompass Health by 5.4% during the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 3,524 shares of the company’s stock worth $428,000 after acquiring an additional 181 shares during the last quarter. Inspire Investing LLC increased its stake in Encompass Health by 66.1% in the third quarter. Inspire Investing LLC now owns 65,010 shares of the company’s stock valued at $7,898,000 after purchasing an additional 25,878 shares in the last quarter. Root Financial Partners LLC bought a new stake in Encompass Health in the third quarter valued at approximately $52,000. Quadrant Capital Group LLC raised its holdings in Encompass Health by 25.0% in the third quarter. Quadrant Capital Group LLC now owns 11,602 shares of the company’s stock worth $1,442,000 after purchasing an additional 2,318 shares during the period. Finally, Nisa Investment Advisors LLC raised its holdings in Encompass Health by 3.1% in the third quarter. Nisa Investment Advisors LLC now owns 17,501 shares of the company’s stock worth $2,126,000 after purchasing an additional 519 shares during the period. 97.25% of the stock is owned by institutional investors.

Insider Buying and Selling at Encompass Health

In related news, EVP John Darby sold 4,858 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $121.09, for a total value of $588,255.22. Following the sale, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,086,714.69. The trade was a 6.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. This represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 186,912 shares of company stock valued at $23,434,845 in the last three months. 1.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

EHC has been the topic of a number of recent analyst reports. Barclays lifted their price target on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. UBS Group upped their price objective on shares of Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Wall Street Zen downgraded Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, October 17th. TD Cowen raised their price objective on Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Finally, Raymond James Financial set a $150.00 target price on Encompass Health in a report on Monday, September 28th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $148.50.

Encompass Health Stock Down 1.4%

Shares of EHC traded down $1.78 on Friday, hitting $124.23. The company’s stock had a trading volume of 805,861 shares, compared to its average volume of 1,087,470. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The firm’s fifty day moving average price is $122.35 and its 200-day moving average price is $112.46. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $129.96. The firm has a market capitalization of $12.26 billion, a price-to-earnings ratio of 20.23, a P/E/G ratio of 2.55 and a beta of 0.74.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%. Encompass Health’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Monday, January 4th. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is currently 13.68%.

Encompass Health Profile

Encompass Health Corporation (NYSE:EHC) is a healthcare services company that operates inpatient rehabilitation hospitals in the United States and Puerto Rico. Its hospitals provide intensive rehabilitation to patients recovering from conditions such as stroke, brain and spinal cord injuries, neurological disorders, amputations, hip fractures and other serious illnesses or injuries.

The company’s services typically include nursing care, physical therapy, occupational therapy, speech and language therapy, respiratory therapy and medical management.